WuXi AppTec Co Ltd (603259)

Currency in CNY
109.55
-1.63(-1.47%)
Closed·
603259 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
106.62111.01
52 wk Range
57.92115.79
Key Statistics
Bid/Ask
109.47 / 109.48
Prev. Close
111.18
Open
110
Day's Range
106.62-111.01
52 wk Range
57.92-115.79
Volume
59.68M
Average Volume (3m)
38.09M
1-Year Change
85.1445%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603259 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
145.41
Upside
+32.74%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years

WuXi AppTec Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Analyst Ratings

21 Buy
1 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 145.41
(+32.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy155.00+41.49%150.00MaintainApr 30, 2026
Citi
Buy160.00+46.05%140.00MaintainApr 28, 2026
Goldman Sachs
Buy151.50+38.29%137.30MaintainApr 28, 2026
Morgan Stanley
Buy145.00+32.36%135.00MaintainApr 27, 2026
Citi
Buy140.00+27.80%138.00MaintainApr 20, 2026

WuXi AppTec Co Ltd Earnings Call Summary for Q3/2025

  • WuXi AppTec beats Q3 2025 expectations with EPS of $1.24 and revenue of $12.06B, stock rises 3.36% to $103.81
  • Revenue up 22.5% YoY to RMB 32.86B for Q1-Q3 2025, driven by small molecule drug discovery and 121.1% growth in TIDES business
  • Full-year revenue guidance raised to RMB 43.5-44.0B, with 17-18% growth expected from continuing operations
  • Operating cash flow improved 35% YoY to RMB 10.87B; company projects free cash flow of RMB 8.0-8.5B for the year
  • Executives emphasize focus on meeting customer demands and maintaining high standards amid potential regulatory challenges
Last Updated: 27/10/2025, 03:24
Read Full Transcript

Earnings

Latest Release
Apr 27, 2026
EPS / Forecast
1.58 / 1.22
Revenue / Forecast
12.44B / 10.89B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.99%
Dividend Yield
1.51%
Industry Median 1.44%
Annualised payout
1.68
Paid annually
5-Years Growth
+44.86%
Growth Streak

603259 Income Statement

Compare 603259 to Peers and Sector

Metrics to compare
603259
Peers
Sector
Relationship
P/E Ratio
17.9x22.6x−0.5x
PEG Ratio
0.230.480.00
Price/Book
4.0x2.8x2.6x
Price / LTM Sales
7.3x4.2x3.2x
Upside (Analyst Target)
28.6%20.3%50.8%
Fair Value Upside
Unlock19.4%7.7%Unlock

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.

Employees
33834
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
879.82M29.49%97.82B
Other Institutional Investors
868.84M29.12%96.60B
Public Companies & Retail Investors
1.24B41.39%137.32B
Total
2.98B100.00%331.73B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hong Kong Exchanges and Clearing Limited10.11%301,537,61633,524,952
Zhongmin Yinfu Capital Management Co., Ltd.2.90%86,589,2599,626,994

People Also Watch

436.00
300750
-2.02%
53.88
600276
-2.02%
857.50
300308
+1.36%
28,260.0
6857
-5.01%

FAQ

What Is the WuXi AppTec (603259) Stock Price Today?

The WuXi AppTec stock price today is 109.55 CNY.

What Stock Exchange Does WuXi AppTec Trade On?

WuXi AppTec is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for WuXi AppTec?

The stock symbol for WuXi AppTec is "603259."

What Is the WuXi AppTec Market Cap?

As of today, WuXi AppTec market cap is 327.35B CNY.

What Is WuXi AppTec's Earnings Per Share (TTM)?

The WuXi AppTec EPS (TTM) is 6.99.

When Is the Next WuXi AppTec Earnings Date?

WuXi AppTec will release its next earnings report on Aug 03, 2026.

From a Technical Analysis Perspective, Is 603259 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has WuXi AppTec Stock Split?

WuXi AppTec has split 3 times.

How Many Employees Does WuXi AppTec Have?

WuXi AppTec has 33834 employees.

What is the current trading status of WuXi AppTec (603259)?

As of Apr 30, 2026, WuXi AppTec (603259) is trading at a price of 109.55 CNY, with a previous close of 111.18 CNY. The stock has fluctuated within a day range of 106.62 CNY to 111.01 CNY, while its 52-week range spans from 57.92 CNY to 115.79 CNY.

What Is WuXi AppTec (603259) Price Target According to Analysts?

The average 12-month price target for WuXi AppTec is 145.41 CNY, with a high estimate of 170 CNY and a low estimate of 124.4 CNY. 21 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +32.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.